Galapagos NV Ownership | Who Owns Galapagos NV?
Galapagos NV Ownership Summary
Galapagos NV is owned by 32.56% institutional investors, and 67.44% retail investors. Gilead sciences is the largest institutional shareholder, holding 25.35% of GLPG shares. PRIMECAP Odyssey Aggressive Growth is the top mutual fund, with 0.81% of its assets in Galapagos NV shares.
GLPG Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Galapagos NV | 32.56% | - | 67.44% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Gilead sciences | 16.71M | 25.35% | $461.73M |
Tang capital management | 2.16M | 3.28% | $59.43M |
Fmr | 1.59M | 2.42% | $43.86M |
Bvf inc/il | 1.57M | 2.38% | $43.16M |
Deerfield management company, l.p. (series c) | 1.41M | 2.14% | $38.80M |
Prosight management, lp | 1.35M | 2.05% | $33.45M |
Deep track capital, lp | 780.78K | 1.18% | $21.47B |
Segall bryant & hamill | 685.87K | 1.04% | $18.86M |
Finepoint capital lp | 674.76K | 1.02% | $18.56M |
Primecap management co/ca/ | 631.21K | 0.96% | $17.36M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Gilead sciences | 16.71M | 29.77% | $461.73M |
Prosight management, lp | 1.35M | 10.00% | $33.45M |
Stonepine capital management | 200.00K | 4.44% | $5.50M |
Tang capital management | 2.16M | 3.93% | $59.43M |
Bvf inc/il | 1.57M | 1.46% | $43.16M |
Newtyn management | 270.00K | 1.29% | $7.42M |
Finepoint capital lp | 674.76K | 1.13% | $18.56M |
Dafna capital management | 130.18K | 0.91% | $3.58M |
Deep track capital, lp | 780.78K | 0.80% | $21.47B |
Deerfield management company, l.p. (series c) | 1.41M | 0.73% | $38.80M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Gilead sciences | 16.71M | 29.77% | 16.71M |
Tang capital management | 2.16M | 3.93% | 1.46M |
Deep track capital, lp | 780.78K | 0.80% | 780.78K |
Prosight management, lp | 1.35M | 10.00% | 418.47K |
Norges bank | 120.00K | 0.00% | 120.00K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Logos global management lp | - | - | -800.00K |
Stonepine capital management | 200.00K | 4.44% | -278.66K |
Newtyn management | 270.00K | 1.29% | -230.00K |
Millennium management | 42.27K | 0.00% | -225.08K |
Wellington management group llp | 345.05K | 0.00% | -129.83K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Gilead sciences | 16.71M | 29.77% | 16.71M | $461.73M |
Deep track capital, lp | 780.78K | 0.80% | 780.78K | $21.47B |
Norges bank | 120.00K | 0.00% | 120.00K | $3.30M |
Woodline partners lp | 45.90K | 0.01% | 45.90K | $1.26M |
Verition fund management | 17.69K | 0.00% | 17.69K | $486.45K |
Sold Out
Holder | Change |
---|---|
Harbor investment advisory | -4.00 |
Jaffetilchin investment partners | -5.00 |
Northwestern mutual wealth management | -10.00 |
Cibc private wealth group | -11.00 |
Eversource wealth advisors | -32.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 47 | -41.98% | 21,455,429 | 58.42% | 32 | 28.68% | 22 | -40.54% | 15 | -37.50% |
Sep 30, 2024 | 81 | -4.71% | 13,543,404 | -32.02% | 10 | 4.34% | 38 | -25.49% | 24 | 41.18% |
Jun 30, 2024 | 82 | -4.65% | 19,897,704 | -2.23% | 30 | 3.16% | 51 | 37.84% | 16 | -42.86% |
Mar 31, 2024 | 86 | -8.51% | 20,352,539 | 2.95% | 30 | 3.47% | 37 | -30.19% | 28 | 47.37% |
Dec 31, 2023 | 94 | 22.08% | 19,770,135 | 3.81% | 29 | 3.51% | 53 | 39.47% | 19 | -5.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
PRIMECAP Odyssey Aggressive Growth | 531.30K | 0.81% | -73.40K |
Fidelity Advisor Equity Growth I | 431.37K | 0.65% | - |
Fidelity VIP Growth Initial | 395.70K | 0.60% | - |
Fidelity Capital Appreciation | 354.70K | 0.54% | - |
Fidelity Growth Discovery | 229.55K | 0.35% | - |
iShares Biotechnology ETF | 212.80K | 0.32% | -2.37K |
Segall Bryant & Hamill Sm Cp Val Ins | 172.80K | 0.26% | -2.14K |
AlphaCentric LifeSci Healthcare I | 108.50K | 0.16% | 3.50K |
AlphaCentric Life Sciences & Hlthcare I | 108.50K | 0.16% | - |
Vanguard US Opportunities Ins USD Acc | 99.91K | 0.15% | -10.90K |
GLPG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools